NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumours without TP53 mutations

被引：0
|
作者：
Prokunina-Olsson, L. [1 ]
Fu, Y. P. [1 ]
Edvardsen, H. [2 ]
Kaushiva, A. [1 ]
Kohaar, I. [1 ]
Porter-Gill, P. [1 ]
Fossa, S. [3 ]
Naume, B. [4 ]
Borresen-Dale, A. L. [2 ]
Kristensen, V. Nedelcheva [2 ]
机构：
[1] NCI, Lab Translat Genom, Bethesda, MD 20892 USA
[2] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Oslo, Norway
[3] Univ Oslo, Norwegian Radium Hosp, Fac Div Med, Oslo, Norway
[4] Oslo Univ Hosp, Radiumhosp, Dept Oncol, Oslo, Norway
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70850-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
    Yi-Ping Fu
    Hege Edvardsen
    Alpana Kaushiva
    Juan P Arhancet
    Tiffany M Howe
    Indu Kohaar
    Patricia Porter-Gill
    Anushi Shah
    Hege Landmark-Høyvik
    Sophie D Fosså
    Stefan Ambs
    Bjørn Naume
    Anne-Lise Børresen-Dale
    Vessela N Kristensen
    Ludmila Prokunina-Olsson
    Molecular Cancer, 9
  • [2] NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
    Fu, Yi-Ping
    Edvardsen, Hege
    Kaushiva, Alpana
    Arhancet, Juan P.
    Howe, Tiffany M.
    Kohaar, Indu
    Porter-Gill, Patricia
    Shah, Anushi
    Landmark-Hoyvik, Hege
    Fossa, Sophie D.
    Ambs, Stefan
    Naume, Bjorn
    Borresen-Dale, Anne-Lise
    Kristensen, Vessela N.
    Prokunina-Olsson, Ludmila
    MOLECULAR CANCER, 2010, 9
  • [3] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [4] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
    Foedermayr, Mathilde
    Sebesta, Miriam
    Rudas, Margaretha
    Berghoff, Anna S.
    Promberger, Regina
    Preusser, Matthias
    Dubsky, Peter
    Gnant, Michael
    Steger, Guenther G.
    Weltermann, Ansgar
    Zielinski, Christoph C.
    Zach, Otto
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 70 - 75
  • [5] Low expression of TP53INP1 gene is an independent factor indicating a poor prognosis in ER-positive breast cancer
    Nishimoto, Mayumi
    Kondo, Naoto
    Endo, Yumi
    Hato, Yukari
    Hisada, Tomoka
    Nishikawa, Sayaka
    Toyama, Tatsuya
    CANCER SCIENCE, 2018, 109 : 657 - 657
  • [6] Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families
    ZeladaHedman, M
    BorresenDale, AL
    Claro, A
    Chen, J
    Skoog, L
    Lindblom, A
    BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1201 - 1204
  • [7] Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families
    M Zelada-Hedman
    A-L Børresen-Dale
    A Claro
    J Chen
    L Skoog
    A Lindblom
    British Journal of Cancer, 1997, 75 : 1201 - 1204
  • [8] Clinical relevance of TP53 mutations and genomic instability in node positive breast cancer
    Kotoula, Vassiliki
    Lakis, Sotiris
    Alexopoulou, Zoi
    Charalambous, Elpida
    Papadopoulou, Kyriaki
    Lyberopoulou, Aggeliki
    Tsolaki, Eleftheria
    Timotheadou, Eleni
    Pectasides, Dimitrios
    Zagouri, Flora
    Pentheroudakis, George
    Koutras, Angelos
    Gogas, Helen
    Kalogeras, Konstantine T.
    Wirtz, Ralph M.
    Fountzilas, George
    CANCER RESEARCH, 2015, 75
  • [9] Early onset HER2-positive breast cancer is associated with germline TP53 mutations
    Melhem-Bertrandt, Amal
    Bojadzieva, Jasmina
    Ready, Kaylene J.
    Obeid, Elias
    Liu, Diane D.
    Gutierrez-Barrera, Angelica M.
    Litton, Jennifer K.
    Olopade, Olufunmilayo I.
    Hortobagyi, Gabriel N.
    Strong, Louise C.
    Arun, Banu K.
    CANCER, 2012, 118 (04) : 908 - 913
  • [10] Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer
    Kotoula, V.
    Zagouri, F.
    Alexopoulou, Z.
    Gogas, H.
    Lakis, S.
    Pentheroudakis, G.
    Bobos, M.
    Papadopoulou, K.
    Tsolaki, E.
    Skondra, M.
    Karavasilis, V.
    Koutras, A.
    Chrisafi, S.
    Christodoulou, C.
    Papakostas, P.
    Linardou, H.
    Markopoulos, C.
    Zografos, G.
    Samantas, E.
    Fountzilas, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S270 - S270
12345